These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 28987960)

  • 21. Protective effect of CCR5-Δ32 against HIV infection by the heterosexual mode of transmission in a Polish population.
    Zwolińska K; Knysz B; Rybka K; Pazgan-Simon M; Gąsiorowski J; Sobczyński M; Gładysz A; Piasecki E
    AIDS Res Hum Retroviruses; 2013 Jan; 29(1):54-60. PubMed ID: 22957692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CCR5 genotype and resistance to vertical transmission of HIV-1.
    Philpott S; Burger H; Charbonneau T; Grimson R; Vermund SH; Visosky A; Nachman S; Kovacs A; Tropper P; Frey H; Weiser B
    J Acquir Immune Defic Syndr; 1999 Jul; 21(3):189-93. PubMed ID: 10421241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency of the CCR5-Delta32 mutant allele is not increased in Belgian hepatitis C virus-infected patients.
    Thoelen I; Verbeeck J; Wollants E; Maes P; Robaeys G; Matheï C; Buntinx F; Nevens F; Van Ranst M
    Viral Immunol; 2005; 18(1):232-5. PubMed ID: 15802968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of 32 alelle of the CCR5 gene in the population of Poland.
    Jagodzinski PP; Lecybył R; Ignacak M; Juszczyk J; Trzeciak WH
    J Hum Genet; 2000; 45(5):271-4. PubMed ID: 11043507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is the European spatial distribution of the HIV-1-resistant CCR5-Delta32 allele formed by a breakdown of the pathocenosis due to the historical Roman expansion?
    Faure E; Royer-Carenzi M
    Infect Genet Evol; 2008 Dec; 8(6):864-74. PubMed ID: 18790087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic expressions of CCR5-delta32/delta32 homozygosity.
    Nguyêñ GT; Carrington M; Beeler JA; Dean M; Aledort LM; Blatt PM; Cohen AR; DiMichele D; Eyster ME; Kessler CM; Konkle B; Leissinger C; Luban N; O'Brien SJ; Goedert JJ; O'Brien TR
    J Acquir Immune Defic Syndr; 1999 Sep; 22(1):75-82. PubMed ID: 10534150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The geographic spread of the CCR5 Delta32 HIV-resistance allele.
    Novembre J; Galvani AP; Slatkin M
    PLoS Biol; 2005 Nov; 3(11):e339. PubMed ID: 16216086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of CCR5 and CCR2 genetic variants in the resistance/susceptibility to HIV in serodiscordant couples from Colombia.
    Zapata W; Aguilar-Jiménez W; Pineda-Trujillo N; Rojas W; Estrada H; Rugeles MT
    AIDS Res Hum Retroviruses; 2013 Dec; 29(12):1594-603. PubMed ID: 24098976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes.
    Stephens JC; Reich DE; Goldstein DB; Shin HD; Smith MW; Carrington M; Winkler C; Huttley GA; Allikmets R; Schriml L; Gerrard B; Malasky M; Ramos MD; Morlot S; Tzetis M; Oddoux C; di Giovine FS; Nasioulas G; Chandler D; Aseev M; Hanson M; Kalaydjieva L; Glavac D; Gasparini P; Kanavakis E; Claustres M; Kambouris M; Ostrer H; Duff G; Baranov V; Sibul H; Metspalu A; Goldman D; Martin N; Duffy D; Schmidtke J; Estivill X; O'Brien SJ; Dean M
    Am J Hum Genet; 1998 Jun; 62(6):1507-15. PubMed ID: 9585595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of three HIV-1 resistance-conferring polymorphisms (SDF1-3'A, CCR2-641, and CCR5-delta32) in global populations.
    Su B; Sun G; Lu D; Xiao J; Hu F; Chakraborty R; Deka R; Jin L
    Eur J Hum Genet; 2000 Dec; 8(12):975-9. PubMed ID: 11175286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The evolutionary history of the CCR5-Delta32 HIV-resistance mutation.
    Galvani AP; Novembre J
    Microbes Infect; 2005 Feb; 7(2):302-9. PubMed ID: 15715976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency of a mutated CCR-5 allele (delta32) among Italian healthy donors and individuals at risk of parenteral HIV infection.
    Zamarchi R; Indraccolo S; Minuzzo S; Coppola V; Gringeri A; Santagostino E; Vicenzi E; De Silvestro G; Biagiotti R; Baldassarre C; Chieco-Bianchi L; Amadori A
    AIDS Res Hum Retroviruses; 1999 Mar; 15(4):337-44. PubMed ID: 10082117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The combination of primary sclerosing cholangitis and CCR5-Δ32 in recipients is strongly associated with the development of nonanastomotic biliary strictures after liver transplantation.
    op den Dries S; Buis CI; Adelmeijer J; Van der Jagt EJ; Haagsma EB; Lisman T; Porte RJ
    Liver Int; 2011 Sep; 31(8):1102-9. PubMed ID: 21134114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
    Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
    Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion.
    Sheppard HW; Celum C; Michael NL; O'Brien S; Dean M; Carrington M; Dondero D; Buchbinder SP
    J Acquir Immune Defic Syndr; 2002 Mar; 29(3):307-13. PubMed ID: 11873082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The HIV-infection outbreak in the town Lys'va (Perm region): homozygote genotype CCR5 delta32/CCR5 delta32 provides the high level of the persistence in the parenteral transmission of the virus].
    Riabov GS; Kazennova EV; Korepanova LB; Mal'tseva EA; Zhalnin VV; Krasnikova LA; Zverev SIa; Pokrovskiĭ VV; Bobkov AF; Weber JN
    Vopr Virusol; 2002; 47(4):13-6. PubMed ID: 12271718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection.
    Marmor M; Sheppard HW; Donnell D; Bozeman S; Celum C; Buchbinder S; Koblin B; Seage GR;
    J Acquir Immune Defic Syndr; 2001 Aug; 27(5):472-81. PubMed ID: 11511825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphism in the CCR5 gene promoter and HIV-1 infection in North Indians.
    Kaur G; Singh P; Rapthap CC; Kumar N; Vajpayee M; Sharma SK; Wanchu A; Mehra NK
    Hum Immunol; 2007 May; 68(5):454-61. PubMed ID: 17462514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in C-C chemokine receptor type 5 (CCR5) in South African individuals.
    Barmania F; Potgieter M; Pepper MS
    Int J Infect Dis; 2013 Dec; 17(12):e1148-53. PubMed ID: 23911155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased HIV type 1 transcription in CCR5-Δ32 heterozygotes during suppressive antiretroviral therapy.
    Wang C; Abdel-Mohsen M; Strain MC; Lada SM; Yukl S; Cockerham LR; Pilcher CD; Hecht FM; Sinclair E; Liegler T; Richman DD; Deeks SG; Pillai SK
    J Infect Dis; 2014 Dec; 210(11):1838-43. PubMed ID: 24935955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.